...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent
【24h】

Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent

机译:含有吲哚片段作为有效和选择性抗癌剂的新型硫代钠衍生物

获取原文
获取原文并翻译 | 示例

摘要

Potent and safe anticancer drugs research and development are still on the way to human health. In this report, a series of novel thiosemicarbazone derivatives containing indole fragment were designed and synthesized. Most compounds exhibited excellent antiproliferative activity against PC3, MGC803 and EC109 cell lines with low micromolar IC50 (0.14-12 mu M). Especially, compound 5j can selectively inhibit PC3 cells in three tested tumor cells with IC50 value of 0.14 mu M, which may be attributed to a synergistic effect after introducing indole fragment into the TSC structure. Meanwhile, compound 5j displayed more selectivity in PC3 cells toward two normal WPMY-1 and GES-1 cell lines, compared to those of 3-AP and DPC. We also found that 5j can effectively inhibit PC3 cell proliferation, colonization and induce apoptosis. What's more, 5j may significantly suppress migration and invasion by blocking the EMT process but had no effect on cell cycle. Collectively, our findings indicate that 5j with structure of thiosemicarbazone containing indole may serve as a useful anticancer lead for further optimization and development. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:有效和安全的抗癌药物研发仍在前往人类健康的路上。在本报告中,设计并合成了一系列含有吲哚片段的新型硫代氧化脲衍生物。大多数化合物对PC3,MGC803和EC109细胞系具有优异的抗增殖活性,具有低微摩尔IC50(0.14-12μm)。特别地,化合物5j可以选择性地抑制三个测试的肿瘤细胞中的PC3细胞,IC50值为0.14μm,其在将吲哚片段引入TSC结构之后可能归因于协同效应。同时,与3-AP和DPC相比,化合物5J在PC3细胞中显示出PC3细胞中的更多选择性朝向两个正常的WPMY-1和GES-1细胞系。我们还发现,5J可以有效抑制PC3细胞增殖,定植和诱导细胞凋亡。更重要的是,5J可以通过阻止EMT过程来显着抑制迁移和侵袭,但对细胞周期没有影响。统称,我们的研究结果表明,5J具有含有吲哚的硫代蓟鸟的结构可以用作进一步优化和发育的有用抗癌。 (c)2019年Elsevier Masson SAS。版权所有。

著录项

  • 来源
  • 作者单位

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

    Zhengzhou Univ Coinnovat Ctr Henan Prov New Drug R&

    D &

    Preclin S State Key Lab Esophageal Canc;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    Thiosemicarbazone; Selectivity; Proliferation; Migration; Apoptosis;

    机译:Thiosimerabazone;选择性;增殖;迁移;细胞凋亡;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号